
Sign up to save your podcasts
Or


Immad and Raj sit down with Celine Halioua, founder and CEO of Loyal, a pioneering biotech company developing drugs to increase lifespan longevity in dogs. This episode highlights the unique challenges of building a biotech company, from navigating FDA approval processes to explaining longevity science to investors. The conversation also explores alternative funding sources beyond traditional VC, with all three founders sharing war stories about their toughest fundraising experiences. Whether you're interested in biotech, startup fundraising, or the future of longevity research, this conversation offers valuable insights into building innovative companies without relying on the typical Silicon Valley playbook.
Want to join the conversation? Connect with us on Tribe:
https://trbcht.com/invites/WmHNjar5ZN
By Immad Akhund and Rajat Suri4.7
1515 ratings
Immad and Raj sit down with Celine Halioua, founder and CEO of Loyal, a pioneering biotech company developing drugs to increase lifespan longevity in dogs. This episode highlights the unique challenges of building a biotech company, from navigating FDA approval processes to explaining longevity science to investors. The conversation also explores alternative funding sources beyond traditional VC, with all three founders sharing war stories about their toughest fundraising experiences. Whether you're interested in biotech, startup fundraising, or the future of longevity research, this conversation offers valuable insights into building innovative companies without relying on the typical Silicon Valley playbook.
Want to join the conversation? Connect with us on Tribe:
https://trbcht.com/invites/WmHNjar5ZN

536 Listeners

9,724 Listeners

1,105 Listeners

2,342 Listeners

233 Listeners

203 Listeners

5,610 Listeners

10,254 Listeners

551 Listeners

150 Listeners

51 Listeners

90 Listeners

34 Listeners

60 Listeners

77 Listeners